Skip to main content
. 2018 Dec 26;27(3):389–400. doi: 10.1016/j.jsps.2018.12.008

Fig. 4.

Fig. 4

Antiviral effects of combination treatment on HBV replication, showing inhibition of HBeAg expressions relative to untreated control at day 5. Values (Y–axis): means of three determinations. Q: Quercetin, B: Baccatin III, P: Psoralen, E: Embelin, M: Menisdaurin, A: Azadirachtin, and L: Lamivudine.